These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 26903266)

  • 21. Gaucher disease.
    Nagral A
    J Clin Exp Hepatol; 2014 Mar; 4(1):37-50. PubMed ID: 25755533
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biomarkers for lysosomal storage disorders: identification and application as exemplified by chitotriosidase in Gaucher disease.
    Aerts JM; van Breemen MJ; Bussink AP; Ghauharali K; Sprenger R; Boot RG; Groener JE; Hollak CE; Maas M; Smit S; Hoefsloot HC; Smilde AK; Vissers JP; de Jong S; Speijer D; de Koster CG
    Acta Paediatr; 2008 Apr; 97(457):7-14. PubMed ID: 18339181
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Imiglucerase low-dose therapy for paediatric Gaucher disease--a long-term cohort study.
    Heitner R; Arndt S; Levin JB
    S Afr Med J; 2004 Aug; 94(8):647-51. PubMed ID: 15352589
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mass spectrometric quantification of glucosylsphingosine in plasma and urine of type 1 Gaucher patients using an isotope standard.
    Mirzaian M; Wisse P; Ferraz MJ; Gold H; Donker-Koopman WE; Verhoek M; Overkleeft HS; Boot RG; Kramer G; Dekker N; Aerts JM
    Blood Cells Mol Dis; 2015 Apr; 54(4):307-14. PubMed ID: 25842368
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical evaluation of chitotriosidase enzyme activity in Gaucher and Niemann Pick A/B diseases: A retrospective study from India.
    Kadali S; Kolusu A; Sunkara S; Gummadi MR; Undamatla J
    Clin Chim Acta; 2016 Jun; 457():8-11. PubMed ID: 26975750
    [TBL] [Abstract][Full Text] [Related]  

  • 26. LC-MS/MS analysis of plasma glucosylsphingosine as a biomarker for diagnosis and follow-up monitoring in Gaucher disease in the Spanish population.
    Irún P; Cebolla JJ; López de Frutos L; De Castro-Orós I; Roca-Espiau M; Giraldo P
    Clin Chem Lab Med; 2020 Apr; 58(5):798-809. PubMed ID: 32126008
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Chitotriosidase of human macrophages and mammalian chitinases: biological functions and abnormalities in pathology].
    Korolenko TA; Cherkanova MS
    Vestn Ross Akad Med Nauk; 2009; (11):39-45. PubMed ID: 20017407
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Decrease of plasma taurine in Gaucher disease and its sustained correction during enzyme replacement therapy.
    vom Dahl S; Mönnighoff I; Häussinger D
    Amino Acids; 2000; 19(3-4):585-92. PubMed ID: 11140361
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma chitotriosidase activity in patients with beta-thalassemia.
    Barone R; Di Gregorio F; Romeo MA; Schilirò G; Pavone L
    Blood Cells Mol Dis; 1999 Feb; 25(1):1-8. PubMed ID: 10349508
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma glucosylceramide and ceramide in type 1 Gaucher disease patients: correlations with disease severity and response to therapeutic intervention.
    Groener JE; Poorthuis BJ; Kuiper S; Hollak CE; Aerts JM
    Biochim Biophys Acta; 2008; 1781(1-2):72-8. PubMed ID: 18155675
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A non-specific biomarker of disease activity in HIV/AIDS patients from resource-limited environments.
    Bipath P; Levay P; Olorunju S; Viljoen M
    Afr Health Sci; 2015 Jun; 15(2):334-43. PubMed ID: 26124777
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biochemical response to substrate reduction therapy versus enzyme replacement therapy in Gaucher disease type 1 patients.
    Smid BE; Ferraz MJ; Verhoek M; Mirzaian M; Wisse P; Overkleeft HS; Hollak CE; Aerts JM
    Orphanet J Rare Dis; 2016 Mar; 11():28. PubMed ID: 27008851
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The biology of the Gaucher cell: the cradle of human chitinases.
    Bussink AP; van Eijk M; Renkema GH; Aerts JM; Boot RG
    Int Rev Cytol; 2006; 252():71-128. PubMed ID: 16984816
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of a panel of highly sensitive, equivalent assays for detection of antibody responses to velaglucerase alfa or imiglucerase enzyme replacement therapy in patients with Gaucher disease.
    Séllos-Moura M; Barzegar S; Pan L; Shi P; Oommen S; Durant J; Ruiz JA
    J Immunol Methods; 2011 Oct; 373(1-2):45-53. PubMed ID: 21846471
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biomarkers in Serbian patients with Gaucher disease.
    Sumarac Z; Suvajdžić N; Ignjatović S; Majkić-Singh N; Janić D; Petakov M; Dorđević M; Mitrović M; Dajak M; Golubović M; Rodić P
    Clin Biochem; 2011 Aug; 44(12):950-4. PubMed ID: 21640089
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Marked elevation of plasma chitotriosidase activity. A novel hallmark of Gaucher disease.
    Hollak CE; van Weely S; van Oers MH; Aerts JM
    J Clin Invest; 1994 Mar; 93(3):1288-92. PubMed ID: 8132768
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Insulin-like growth factors in childhood-onset Gaucher disease.
    Rite S; Baldellou A; Giraldo P; Labarta JI; Giralt M; Rubio-Felix D; Guallar A; Perez-Calvo JI; Mayayo E; Ferrandez A; Pocovi M
    Pediatr Res; 2002 Jul; 52(1):109-12. PubMed ID: 12084856
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Haemorheology in Gaucher disease.
    Bax BE; Richfield L; Bain MD; Mehta AB; Chalmers RA; Rampling MW
    Eur J Haematol; 2005 Sep; 75(3):252-8. PubMed ID: 16104883
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enzymatic analysis of biomarkers for the monitoring of Gaucher patients in Colombia.
    Pacheco N; Uribe A
    Gene; 2013 May; 521(1):129-35. PubMed ID: 23523857
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Coagulation abnormalities in type 1 Gaucher disease in children.
    Deghady A; Marzouk I; El-Shayeb A; Wali Y
    Pediatr Hematol Oncol; 2006; 23(5):411-7. PubMed ID: 16728361
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.